Men are at high risk for HPV infection and can benefit from vaccination, but vaccination rates
among men remain extremely low. More research needs to be done on the predictors of …

Background and aims Infection with high‐risk (HR) genotypes of the human papillomavirus
(HPV) is necessary for and causative of almost all cervical cancers and their precursor …

Human papillomavirus (HPV) is an extremely prevalent sexually transmitted infection that is
typically acquired soon after onset of sexual activity. The burden of HPV-related malignant …

Objectives: HPV vaccine acceptability was examined as part of a cohort study of HPV
infection among adult males. Methods: Between July 2004 and June 2007, 445 adult males …

Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …

Background: For human papillomavirus (HPV) vaccination to have maximum benefit to
public health, both men and women should be vaccinated. Although efficacy trials in men …

Objectives Better outcomes of human papillomavirus (HPV) vaccination would be expected
if men become full partners and advocates in vaccination initiative. Men involvement has …

Objective To understand rates of human papillomavirus (HPV) vaccine acceptability and
factors correlated with HPV vaccine acceptability. Design Meta-analyses of cross-sectional …

Context Human papillomavirus (HPV) is the commonest sexually transmitted pathogen in
humans and is linked to the aetiopathogenesis for both benign and malignant disease in …

Objectives. To determine men's attitudes toward receiving the human papillomavirus (HPV)
vaccine. Materials and Methods. Five hundred seventy-one men read a 1-page …